Current Drug Targets
Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Ranking and Category
-
131st of 267 in
Pharmacology & Pharmacy
Most Cited Articles
Review Article
Cytochrome P450 structure, function and clinical significance: A review
, 2018; 19(1): 38-54.Palrasu Manikandan and Siddavaram Nagini*
DOI: 10.2174/1389450118666170125144557
Review Article
Cyclin-dependent kinase 2 in cellular senescence and cancer. A structural and functional review
, 2019; 20(7): 716-726.Priscylla Andrade Volkart, Gabriela Bitencourt-Ferreira, André Arigony Souto* and Walter Filgueira de Azevedo *
DOI: 10.2174/1389450120666181204165344
Review Article
PARP inhibitor drugs in the treatment of breast, ovarian, prostate and pancreatic cancers: An update of clinical trials
, 2018; 19(1): 21-37.Dalia Kamel*, Christopher Gray, Jagdeep Singh Walia and Vikaash Kumar*
DOI: 10.2174/1389450118666170711151518
Review Article
Recent advances in protein tyrosine phosphatase 1b targeted drug discovery for Type II diabetes and obesity
, 1 April 2018; 19(5): 551-575.Neelesh Maheshwari, Chandrabose Karthikeyan, Piyush Trivedi and N.S. Hari Narayana Moorthy*
DOI: 10.2174/1389450118666170222143739
Review Article
Flavonoids and its neuroprotective effects on brain ischemia and neurodegenerative diseases
, 2018; 19(14): 1710-1720.Manish Putteeraj, Wei Ling Lim, Seong Lin Teoh and Mohamad Fairuz Yahaya*
DOI: 10.2174/1389450119666180326125252
Review Article
Clinical, prognostic and therapeutic significance of heat shock proteins in cancer
, 2018; 19(13): 1478-1490.Jasleen Saini and Pushpender Kumar Sharma*
DOI: 10.2174/1389450118666170823121248
Review Article
Nanoparticles in cancer treatment: Opportunities and obstacles
, 2018; 19(14): 1696-1709.Rajendra Awasthi*, Ariane Roseblade, Philip Michael Hansbro, Michael John Rathbone, Kamal Dua and Mary Bebawy*
DOI: 10.2174/1389450119666180326122831
Review Article
Stimuli-responsive smart liposomes in cancer targeting
, 1 March 2018; 19(3): 259-270.Ankit Jain and Sanjay K. Jain*
DOI: 10.2174/1389450117666160208144143
Review Article
Insights into the targeting potential of thymoquinone for therapeutic intervention against triple-negative breast cancer
, 2018; 19(1): 70-80.Md Abul Barkat, Harshita, Javed Ahmad, Mohammad Ahmed Khan*, Sarwar Beg* and Farhan Jalees Ahmad*
DOI: 10.2174/1389450118666170612095959
Review Article
GRP78 influences chemoresistance and prognosis in cancer
, 2018; 19(6): 701-708.Jenifer B. Gifford and Reginald Hill*
DOI: 10.2174/1389450118666170615100918
Review Article
Antitumor activity of polysaccharides: An overview
, 2018; 19(1): 89-96.Ling Chen and Gangliang Huang*
DOI: 10.2174/1389450118666170704143018
Review Article
CDK9 as an appealing target for therapeutic interventions
, 2019; 20(4): 453-464.Shirin Eyvazi, Mohammad Saeid Hejazi, Homan Kahroba, Mozghan Abasi, Reza Eghdam Zamiri and Vahideh Tarhriz*
DOI: 10.2174/1389450119666181026152221
Review Article
Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD
, 2018; 19(16): 1882-1896.Konstantinos Kostikas, Caterina Brindicci and Francesco Patalano*
DOI: 10.2174/1389450119666180212120012
Review Article
Metformin, a new era for an old drug in the treatment of immune mediated disease?
, 2018; 19(8): 945-959.Mark Schuiveling, Nadia Vazirpanah, Timothy R.D.J. Radstake, Maili Zimmermann* and Jasper C.A. Broen*
DOI: 10.2174/1389450118666170613081730
Review Article
Current status and perspectives on pharmacologic therapy for abdominal aortic aneurysm
, 2018; 19(11): 1265-1275.Koichi Yoshimura*, Noriyasu Morikage, Shizuka Nishino-Fujimoto, Akira Furutani, Bungo Shirasawa and Kimikazu Hamano
DOI: 10.2174/1389450119666171227223331
  |
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net